Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/14/2013US20130303530 Methods for treating chronic pelvic pain syndrome with antibodies that binds mcp-1 or mip-1a
11/14/2013US20130303529 Fused heterocyclic derivatives and methods of use
11/14/2013US20130303528 CB2 Receptor Modulators in Neurodegenerative Diseases and Applications of the Same
11/14/2013US20130303524 Carbazole-Containing Sulfonamides as Cryptochrome Modulators
11/14/2013US20130303523 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
11/14/2013US20130303519 Methods of treating cancer using aurora kinase inhibitors
11/14/2013US20130303518 Methods of Inhibiting the Catalytic Activity of a Protein Kinase and of Treating a Protein Kinase Related Disorder
11/14/2013US20130303517 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
11/14/2013US20130303515 Novel compounds useful for the treatment of metabolic and inflammatory diseases
11/14/2013US20130303512 Use of modulators of CCR5 in the treatment of Cancer and cancer metastasis
11/14/2013US20130303511 Nampt inhibitors
11/14/2013US20130303510 Nampt inhibitors
11/14/2013US20130303509 Nampt inhibitors
11/14/2013US20130303508 Nampt inhibitors
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303505 Tgr5 agonists
11/14/2013US20130303504 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
11/14/2013US20130303501 Pharmaceutical composition and method for treating hypogonadism
11/14/2013US20130303498 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
11/14/2013US20130303497 Deuterated 5-ht1a receptor agonists
11/14/2013US20130303496 Method Of Treating Vascular Lesions
11/14/2013US20130303495 Emulsion formulations
11/14/2013US20130303494 Pharmaceutical Formulation Containing Gelling Agent
11/14/2013US20130303493 Triazole Compounds that Modulate HSP90 Activity
11/14/2013US20130303492 3,5-diaminopyrazole kinase inhibitors
11/14/2013US20130303490 Inhibitors of HIV Infections and uses thereof
11/14/2013US20130303489 Multikinase inhibitors for use in the treatment of cancer
11/14/2013US20130303488 Compositions Comprising Zoledronic Acid or Related Compounds for Treatment of Complex Regional Pain Syndrome
11/14/2013US20130303487 Compositions Comprising Zoledronic Acid or Related Compounds for Relieving Inflammatory Pain and Related Conditions
11/14/2013US20130303486 Compositions Comprising Zoledronic Acid or Related Compounds for Relieving Pain Associated with Arthritis
11/14/2013US20130303485 Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
11/14/2013US20130303484 Prodrugs of Modulators of ABC Transporters
11/14/2013US20130303482 Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors
11/14/2013US20130303481 Treatment of myelosuppression
11/14/2013US20130303479 Antiretroviral Cyclonucleoside Compositions and Methods and Articles of Title of Invention Manufacture Therewith
11/14/2013US20130303478 Maintenance of Platelet Inhibition During Antiplatelet Therapy
11/14/2013US20130303477 Maintenance of Platelet Inhibition During Antiplatelet Therapy
11/14/2013US20130303476 Aminoglycoside and Fosfomycin Combination for Treatment of Ventilator Associated Pneumonia (VAP) and Ventilator Associated Tracheal (VAT) Bronchitis
11/14/2013US20130303475 Tobramycin formulation
11/14/2013US20130303474 Composition for enhancing immunity containing compounds represented by chemical formulas 1-8 or sophora flavescens extract as active ingredient
11/14/2013US20130303471 Novel pyrazole compounds
11/14/2013US20130303470 Plant extraction method and compositions
11/14/2013US20130303469 Extraction method for ilex kudingcha c. j. tseng leaves, total saponins and use thereof
11/14/2013US20130303468 Vicenin 2 and analogues thereof for use as an antispasmodic and/or prokinetic agent
11/14/2013US20130303467 Crystal structures of sglt2 inhibitors and processes for preparing same
11/14/2013US20130303466 Chemosensory Receptor Ligand-Based Therapies
11/14/2013US20130303462 Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
11/14/2013US20130303446 Pharmaceutical combinations for the treatment of metabolic disorders
11/14/2013US20130303437 Antimicrobial therapy for bacterial infections
11/14/2013US20130302889 Differentiation of Bone Marrow Cells into Neuronal Cells and Uses Therefor
11/14/2013US20130302863 Compositions containing high omega-3 and low saturated fatty acid levels
11/14/2013US20130302448 Phytin aqueous solution and use of said solution for the preparation of a liquid nutritional supplement or a cosmetic composition
11/14/2013US20130302444 Method for Treating Hearing Loss
11/14/2013US20130302442 Methods of using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide
11/14/2013US20130302441 Methods for the treatment of skin neoplasms
11/14/2013US20130302431 Polymorph Compositions, Methods of Making, and Uses Thereof
11/14/2013US20130302430 Modified and immediate release formulations of memantine
11/14/2013US20130302423 Aerosol Formulation of Aminoglycoside and Fosfomycin Combination for Treatment of Ventilator Associated Pneumonia (VAP) and Ventilator Associated Tracheal (VAT) Bronchitis
11/14/2013US20130302420 Ocular biodegradable drug implant and method of its use
11/14/2013US20130302418 Controlled release hydrocodone formulations
11/14/2013US20130302417 Methods of treatment using a gastric retained gabapentin dosage form
11/14/2013US20130302416 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
11/14/2013US20130302415 Pharmaceutical Composition
11/14/2013US20130302412 Transfer Factor Compositions
11/14/2013US20130302410 Neuroprotection in Demyelinating Diseases
11/14/2013US20130302407 Bi-Functional Short-Hairpin RNA (Bi-shRNA) Specific for Single-Nucleotide KRAS Mutations
11/14/2013US20130302403 Vivo Delivery of Double Stranded RNA to an Interleukin-12 Producing Organ or Tissue
11/14/2013US20130302402 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
11/14/2013US20130302400 Combination therapy with an anti-hyaluronan agent and therapeutic agent
11/14/2013US20130302398 Intraocular drug delivery device and associated methods
11/14/2013US20130302384 Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
11/14/2013US20130302382 Exercise Performance-Increasing Nutritional Supplement and Related Methods and Compositions
11/14/2013US20130302380 Agent for inducing interferon production containing lactic acid bacteria
11/14/2013US20130302379 Method for Preparing Pharmaceutical Composition for Enhancing Immunity and Pharmaceutical Composition Prepared According to the Method
11/14/2013US20130302378 Matrix metalloproteinase inhibitors
11/14/2013US20130302377 Stimulating immune response
11/14/2013US20130302357 Novel benzodiazepine derivatives
11/14/2013US20130302352 Methods for the prevention and/or treatment of memory impairment
11/14/2013US20130302344 Methods and medicaments for the treatment of gout or pseudogout
11/14/2013US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt
11/14/2013US20130302337 Methods and compositions for treating alzheimer's disease
11/14/2013US20130302332 Method for treating inflammation
11/14/2013US20130302327 Marker for determination of sensitivity to triplet combination anti-cancer agent
11/14/2013US20130302324 Methods for treating retinopathy with extended therapeutic effect
11/14/2013US20130302323 Methods for treating diffuse large b-cell lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
11/14/2013US20130302319 Zeaxanthin for tumor treatment
11/14/2013US20130302318 Anti-CD38 Antibody and Lenalidomide or Bortezomib for the Treatment of Multipe Myeloma and NHL
11/14/2013US20130302317 Siglec-9 Binding Agents
11/14/2013US20130302305 Methods for Treating Gout in Patients Subpopulations
11/14/2013US20130302303 Protein kinase inhibitors
11/14/2013US20130302297 Monounsaturated fatty acid for preventing and/or treating skin complexion imperfections
11/14/2013US20130302291 Compositions and methods for cell transplantation
11/14/2013US20130302284 Modulating oncolytic vsv and upregulating rae1 and nup98 with statins
11/14/2013US20130302282 Inhibitors of Hepatitis C Virus
11/14/2013US20130302280 Inhibitors of flaviviridae viruses
11/14/2013US20130302264 Indole alkaloid compounds as melanogenesis promoters and uses thereof
11/14/2013US20130302260 Novel propellant containing preparations for tiotropium
11/14/2013US20130302259 Effervescent compositions containing n-acetylcysteine
11/14/2013US20130302254 Antivenom
11/14/2013US20130298911 Oral care method and kit
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 7860